MATTHEW S. DAVIDS, MD

Director, Clinical Research, Division of Lymphoma

Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School Boston, Massachusetts, USA

PROF. ANDREW DAVIES

Professor, Haematologcal Oncology and Honorary Consultant

Dr. Kieron Dunleavy

Director of Hematology at Lombardi Comprehensive Cancer Center, Georgetown University Washington DC

He is a Professor of Medicine at Georgetown University and completed fellowships in Dublin, Ireland and subsequently at the NCI

STEVEN HORWITZ, MD

STEVEN HORWITZ, MD

is an Attending Physician at the Memorial Hospital for Cancer and Allied Diseases in New York

TIM ILLIDGE, MD

Professor, Targeted Therapy and Oncology, University of Manchester

Honorary Consultant, Clinical Oncology, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

BRAD KHAL, MD

BRAD KHAL, MD

Is a Professor of Medicine and Director of the Lymphoma Program at Washington University School of Medicine, St. Louis

WON SEOG KIM, MD, PhD

Professor and Head of Malignant Lymphoma Center

Division of Hematology-Oncology Sungkyunkwan University Samsung Medical Center Seoul, Korea

THOMAS P. LOUGHRAN, JR., MD

Director, UVA Cancer Center

F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine Co-Director of the Paul Mellon Urologic Cancer-UVA

Grzegorz Nowakowsky, MD

Associate Professor of Medicine, Consultant and Lead of Aggressive Lymphoma Program, Mayo Clinic, Rochester, Minnesota

OWEN O’CONNOR, MD, PhD

Founding Director

Center of Lymphoid Malignancies Department of Medicine, New York Presbyterian Hospital Columbia University Medical Center New York, U.S.A

LISA RIMSZA, M.D.

Professor, Clinician Investigator, and Consultant

Division of Hematopathology Mayo Clinic Arizona Scottsdale, Arizona

JULIA SCARISBRICK, MD

Consultant Dermatologist

Head, Cutaneous Lymphoma Service University Hospital Birmingham, United Kingdom

LAURIE SEHN, MD, MPH

Clinical Assistant Professor

University of British Columbia BC Cancer Agency Vancouver, Canada

MICHAEL WANG, MD

MICHAEL WANG, MD

Dr. Wang obtained his M.D. from Shandong Medical University and M.S. from Beijing University, Medical School

PIER LUIGI ZINZANI, MD, PhD

PIER LUIGI ZINZANI, MD, PhD

Prof. Zinzani is a member of the Italian Society of Hematology, the Italian Society of Experimental

EMANUELE ZUCCA, MD, PhD

Working at the Division of Medical Oncology of the Oncology Institute of Southern Switzerland (IOSI) since 1989

Consultant and the Head of the Lymphoma Unit Leader of (International Extranodal Lymphoma Study Group) at the Institute of Oncology Research

PROF. DAVID LEWIS